BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24475238)

  • 1. Increased Ndfip1 in the substantia nigra of Parkinsonian brains is associated with elevated iron levels.
    Howitt J; Gysbers AM; Ayton S; Carew-Jones F; Putz U; Finkelstein DI; Halliday GM; Tan SS
    PLoS One; 2014; 9(1):e87119. PubMed ID: 24475238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ndfip1 attenuated 6-OHDA-induced iron accumulation via regulating the degradation of DMT1.
    Jia W; Xu H; Du X; Jiang H; Xie J
    Neurobiol Aging; 2015 Feb; 36(2):1183-93. PubMed ID: 25467637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divalent metal transporter 1 (DMT1) regulation by Ndfip1 prevents metal toxicity in human neurons.
    Howitt J; Putz U; Lackovic J; Doan A; Dorstyn L; Cheng H; Yang B; Chan-Ling T; Silke J; Kumar S; Tan SS
    Proc Natl Acad Sci U S A; 2009 Sep; 106(36):15489-94. PubMed ID: 19706893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-Nitrosylation of Divalent Metal Transporter 1 Enhances Iron Uptake to Mediate Loss of Dopaminergic Neurons and Motoric Deficit.
    Liu C; Zhang CW; Lo SQ; Ang ST; Chew KCM; Yu D; Chai BH; Tan B; Tsang F; Tai YK; Tan BWQ; Liang MC; Tan HT; Tang JY; Lai MKP; Chua JJE; Chung MCM; Khanna S; Lim KL; Soong TW
    J Neurosci; 2018 Sep; 38(39):8364-8377. PubMed ID: 30104344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ndfip1 protected dopaminergic neurons via regulating mitochondrial function and ferroptosis in Parkinson's disease.
    Fu X; Qu L; Xu H; Xie J
    Exp Neurol; 2024 May; 375():114724. PubMed ID: 38365133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron status and lipopolysaccharide regulate Ndfip1 by activation of nuclear factor-kappa B.
    Xu H; Chang Q; Jia W; Jiang H; Sun P; Xie J
    Biometals; 2013 Dec; 26(6):981-8. PubMed ID: 24045929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ndfip1-deficient mice have impaired DMT1 regulation and iron homeostasis.
    Foot NJ; Leong YA; Dorstyn LE; Dalton HE; Ho K; Zhao L; Garrick MD; Yang B; Hiwase D; Kumar S
    Blood; 2011 Jan; 117(2):638-46. PubMed ID: 20959604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell type-specific lipid storage changes in Parkinson's disease patient brains are recapitulated by experimental glycolipid disturbance.
    Brekk OR; Honey JR; Lee S; Hallett PJ; Isacson O
    Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27646-27654. PubMed ID: 33060302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron transport in Parkinson's disease.
    Hirsch EC
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S209-11. PubMed ID: 20082992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the divalent metal ion transporter DMT1 and iron homeostasis by a ubiquitin-dependent mechanism involving Ndfips and WWP2.
    Foot NJ; Dalton HE; Shearwin-Whyatt LM; Dorstyn L; Tan SS; Yang B; Kumar S
    Blood; 2008 Nov; 112(10):4268-75. PubMed ID: 18776082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease.
    Davies SE; Hallett PJ; Moens T; Smith G; Mangano E; Kim HT; Goldberg AL; Liu JL; Isacson O; Tofaris GK
    Neurobiol Dis; 2014 Apr; 64(100):79-87. PubMed ID: 24388974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 triggers toxic neuronal iron sequestration in response to pathological α-synuclein.
    Sterling JK; Kam TI; Guttha S; Park H; Baumann B; Mehrabani-Tabari AA; Schultz H; Anderson B; Alnemri A; Chou SC; Troncoso JC; Dawson VL; Dawson TM; Dunaief JL
    Cell Rep; 2022 Feb; 38(7):110358. PubMed ID: 35172141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
    Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
    J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrogating Parkinson's disease associated redox targets: Potential application of CRISPR editing.
    Artyukhova MA; Tyurina YY; Chu CT; Zharikova TM; Bayır H; Kagan VE; Timashev PS
    Free Radic Biol Med; 2019 Nov; 144():279-292. PubMed ID: 31201850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease.
    Gründemann J; Schlaudraff F; Haeckel O; Liss B
    Nucleic Acids Res; 2008 Apr; 36(7):e38. PubMed ID: 18332041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron overload induced by IRP2 gene knockout aggravates symptoms of Parkinson's disease.
    Ci YZ; Li H; You LH; Jin Y; Zhou R; Gao G; Hoi MPM; Wang C; Chang YZ; Yu P
    Neurochem Int; 2020 Mar; 134():104657. PubMed ID: 31904393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-onset Parkinsonism in NFκB/c-Rel-deficient mice.
    Baiguera C; Alghisi M; Pinna A; Bellucci A; De Luca MA; Frau L; Morelli M; Ingrassia R; Benarese M; Porrini V; Pellitteri M; Bertini G; Fabene PF; Sigala S; Spillantini MG; Liou HC; Spano PF; Pizzi M
    Brain; 2012 Sep; 135(Pt 9):2750-65. PubMed ID: 22915735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.